Israeli Stocks: AudioCodes, Nova, Bezeq, Koor, Teva, Brainsway

Israel’s TA-25 Index declined the most since Oct. 4, dropping 2.8 percent to 1,102.07 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.38 billion shekels ($377 million) of shares and convertible securities, according to bourse data.

The following stocks rose or fell today. Symbols are in parentheses.

AudioCodes Ltd. (AUDC) tumbled the most in almost a month, retreating 11 percent to 11.59 shekels. The maker of Internet telephony equipment reported a third-quarter loss of $527,000 after a profit of $2.9 million a year earlier.

Bezeq Israeli Telecommunication Corp. (BEZQ IT) declined the most since Oct. 2, slumping 4.1 percent to 7.41 shekels. Clal Finance Brokerage Ltd. cut its share-price estimate on the country’s largest fixed-line phone company to 8.3 shekels from 9.4 shekels.

Brainsway Ltd. (BRIN) rose for the first time in three days, jumping 3.8 percent to 20.68 shekels. The maker of devices to treat neurological disorders received U.S. Food and Drug Administration approval to begin a multicenter trial to test the efficacy of its Deep TMS device to treat bipolar disorder.

Koor Industries Ltd. (KOR) , the owner of 26.2 million shares of Credit Suisse Group AG as of Aug. 14, declined the most since Sept. 11, slumping 5.7 percent to 42 shekels. Switzerland’s second-biggest bank reported third-quarter earnings that missed analysts’ estimates. Koor’s controlling shareholder Discount Investment Corp. (DISI) lost 4.9 percent to 36.67 shekels.

Micronet Ltd. (MCRNL IT) soared the most in two years, surging 22 percent to 1.413 shekels. The manufacturer of mobile- data collection products received a 20 million-shekel follow-on order from a U.S. client.

Nova Measuring Instruments Ltd. (NVMI) slid the most since Oct. 2, dropping 4.8 percent to 25.82 shekels. The developer of monitoring and measurement systems for the semiconductor industry said third-quarter net income fell to $5.9 million from $7.3 million a year earlier.

Teva Pharmaceutical Industries Ltd. (TEVA) retreated the most since Oct. 9, declining 1.7 percent to 146 shekels. Harel Finance Ltd. cut its share-price estimate for the world’s largest generic drugmaker to 200 shekels from 247 shekels. The company is scheduled to report third-quarter results tomorrow.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.